US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.67

+0.41001.04%

Pre-market: 39.910.2400+0.60%04:00 EDT

Volume:75.38K

Turnover:2.97M

Market Cap:259.84M

PE:- -

High:39.69

Open:39.05

Low:39.05

Close:39.26

52wk High:41.49

52wk Low:22.18

Shares:6.55M

Float Shares:6.55M

Volume Ratio:0.54

T/O Rate:1.15%

Dividend:0.28

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale

Incyte Partner Knight Seeks Supplemental Approval for Minjuvi Combination in Brazil

MT Newswires Live

US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech

Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Twist Bioscience CEO Emily Leproust Sells USD 6.28 Million in Common Shares

Moderna Wins FDA Approval for Updated 2026-2027 COVID-19 Vaccines Targeting JN.1-Lineage XFG Subvariant

Moderna - FDA Approved Sbla for 2026-2027 Formulas for Spikevax and Mnexspike

THOMSON REUTERS

Moderna - Updated Formula for Spikevax is NOW Approved for Individuals 6 Months Through 64 Years of Age with at Least One Underlying Condition

THOMSON REUTERS

Moderna: Updated Covid-19 Vaccines Expected Available in Coming Days

THOMSON REUTERS

Moderna Inc Stock (MRNA) Moved Down by 5.69% on Aug 27: Key Drivers Unveiled

Sector Update: Healthcare

MT Newswires Live

Revolution Medicines' Rasonque Label Expands Commercial Opportunity, Oppenheimer Says

MT Newswires Live

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Moderna Shares Down 3.6% After Co Announces $2 Bln Convertible Debt Plans

THOMSON REUTERS

Moderna Stock (MRNA) Slides 3% on Plans for a $2B Private Placement

AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference

Moderna Falls After Unveiling $2 Bln Convertible Debt Plans

Moderna to Sell $2 Billion Convertible Notes in Private Placement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/IDNA/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":39.67,"timestamp":1788292800000,"preClose":39.26,"halted":0,"volume":75380,"hourTrading":{"tag":"盘前","latestPrice":39.91,"preClose":39.67,"latestTime":"04:00 EDT","volume":5,"amount":199.54999999999998,"timestamp":1788336002761,"change":0.24,"changeRate":0.00605,"amplitude":0},"delay":0,"changeRate":0.010443199184921134,"floatShares":6550000,"shares":6550000,"eps":0,"marketStatus":"Pre-Mkt","change":0.41,"latestTime":"09-02 07:47:13 EDT","open":39.05,"high":39.6899,"low":39.05,"amount":2972722.6162,"amplitude":0.016299,"askPrice":39.84,"askSize":20,"bidPrice":33.43,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":39.67,"sharesOutstanding":5100000,"nav":39.190942,"aum":256700670.1,"dividendRate":0.007131,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.91,"preClose":39.67,"latestTime":"04:00 EDT","volume":5,"amount":199.54999999999998,"timestamp":1788336002761,"change":0.24,"changeRate":0.00605,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":35.74,"preClose":39.67,"latestTime":"19:30 EDT","volume":829,"amount":32033.95,"timestamp":1788305400694,"change":-3.93,"changeRate":-0.099067,"amplitude":0.099067},"volumeRatio":0.5417424869162961,"impliedVol":0.0718,"impliedVolPercentile":0.0598},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6550000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5417424869162961,"shares":6550000,"dividePrice":0.2829,"high":39.6899,"amplitude":0.016299,"preClose":39.26,"low":39.05,"week52Low":22.18,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":39.67,"committee":0.666667,"eps":0,"divideRate":0.007131,"volume":75380,"delay":0,"ttmEps":0,"open":39.05,"prevYearClose":26.19,"prevWeekClose":39.29,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":41.48,"twentyDayClose":32.9055,"sixtyDayClose":29.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662062748","title":"Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062748","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662062748?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:19","pubTimestamp":1787915947,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna rises after upsized $2.6 bln convertible bond sale** Biotech firm Moderna'sMRNA.Oshares up 1.2% at $144.50 before the bell on Fri after it raises more capital than planned** Cambridge, Massachusetts-based MRNA announces pricing private offering of $2.6 bln 0% convertible bonds due March 1 2032** Conversion price of $210.58 represents 47.5% premium over stock's last close of $142.77** MRNA shares finished down 4.6% on Thurs after counveiled$2 bln offering for general corp purposes, including to grow its oncology business and repay debt** Co expects to use approx $285 mln of net proceeds to pay cost of capped call transactions; cap price of $392.62 is 175% above stock's last sale** On Aug 19, MRNA shares soared 177% to $174.38, a 3-1/2 year high, after co said itsskin cancer vaccine, combined with Merck'sMRK.NKeytruda, reduced risk of recurrence and spread of melanoma in a late-stage trial** Through Thurs, MRNA shares up 384% YTD** Avg rating of 23 analysts is \"hold\"; median","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P0MB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4534","LGHT","BK4548","BK4585","BK4588","BK4533","BK4568","MRNA","IDNA","WDNA","BK4139","BK4551","MRNY","BK4501","MRNX","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061139","title":"Incyte Partner Knight Seeks Supplemental Approval for Minjuvi Combination in Brazil","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061139","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061139?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:26","pubTimestamp":1787912783,"startTime":"0","endTime":"0","summary":"Incyte  partner Knight Therapeutics has submitted a supplemental application to the Brazilian health regulatory agency seeking approval for an additional indication for Minjuvi in combination with other medicines as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma or high-grade B-cell lymphoma, the company said Thursday.The drug combination consists of Minjuvvi and lenalidomide added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, the company said.The application is meant to expand Minjuvi in earlier lines of cancer therapy in Brazil, the company said.The supplemental submission is based on previous approvals and results from a phase 3 trial, the company said.Knight has exclusive supply and distribution rights for Incyte's Minjuvi, which is also called Monjuvi, in the US and parts of Latin America, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4550","BK4532","IDNA","EWZS","INCY","BK4139","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145744656","title":"US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=1145744656","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145744656?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:24","pubTimestamp":1787912643,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has officially approved Revolution Medicines' self-developed pancreatic cancer treatment, Rasonque, this week. This approval represents a significant triumph for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","IDNA","LABU","IE00BJT1NW94.SGD","BK4585","IE0002141913.USD","BK4139","CANC","LU0109394709.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4588","LU0320765992.SGD","PTH","IE00BJJMRZ35.SGD","RVMD","IE00B4R5TH58.HKD","BBH","IE0009354923.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662037671","title":"Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037671","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037671?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:21","pubTimestamp":1787880060,"startTime":"0","endTime":"0","summary":"Earlier this year, an oncology biotech with no drugs on the market-just promising research-was attracting takeover interest. Revolution Medicines stayed independent.This week, that bet paid off.The 12","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","PTH","CANC","BBH","RVMD","IE0009355771.USD","LU0320765992.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0109394709.USD","IE0009354923.USD","BK4139","IE00BJT1NW94.SGD","IDNA","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035516","title":"FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035516","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035516?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:04","pubTimestamp":1787864640,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech.The agency gave a green light to supplemental biologics license applications for the 2026-2027 formulas to the Comirnaty vaccine, made by Pfizer and BioNTech, and Moderna's mNexspike and Spikevax shots. The new formulas are designed to target the XFG variant of Covid-19.Pfizer and BioNTech said the new formulation of its vaccine would begin shipping immediately for use beginning in the fall. Moderna said its updated vaccines will be available in the coming days.All three vaccines were approved for adults 65 years of age and older. The FDA also approved the shots for individuals younger than 65 whose underlying conditions put them at high risk for severe outcomes from Covid-19. Those approvals extend as young as 12 years old for mNexspike, five years for Comirnaty, and six months for Spikevax.\"Our updated COVID-19 vaccines help protect those at high risk of severe diseas","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","LU1066051498.USD","LU0225771236.USD","IE00B3T34201.USD","OZEM","BK4534","BK4501","IE00BBT3K403.USD","IE00BLSP4452.SGD","SG9999002232.USD","BK4581","SG9999002224.SGD","MRNA","IE000M9KFDE8.USD","LU0122379950.USD","LU2596442595.SGD","BK4592","LU0225284248.USD","SG9999013999.USD","LU1894683264.USD","BK4551","LU0321505439.SGD","SG9999001176.USD","LU1023059063.AUD","SGXZ57979304.SGD","IE00B19Z3581.USD","LGHT","BK4535","BK4599","IDNA","IE00BLSP4239.USD","MRNX","IE0002270589.USD","LU0321505868.SGD","BK4588","LU1883839398.USD","BK4568","LU0985481810.HKD","LU0170899867.USD","BNTX","LU0234572021.USD","LU0058720904.USD","BK4139","BK4007","BK4532","BK4585","SG9999001176.SGD","WDNA","LU0306806265.USD","PFE","IE00B19Z3B42.SGD","BK4550","LU1894683348.USD","LU0306807586.USD","LU1066053197.SGD","LU1057294990.SGD","SG9999003800.SGD","SG9999011175.SGD","GNOM","BK4533","LU0456855351.SGD","LU0868494617.USD","MRNY","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033626","title":"Moderna Inc. Stock Slips 4.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033626?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:34","pubTimestamp":1787862840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 4.6% to $142.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.6% to 26,541.35 and the Dow Jones Industrial Average rising 0.2% to 53,569.44.This was the stock's second consecutive day of losses.Moderna Inc. closed 19.2% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.6% to $265.77, Pfizer Inc. fell 1.0% to $28.02, and Gilead Sciences Inc. rose 0.52% to $148.86.Trading volume totaled 24.9 million, compared to the 50-day average of 16.4 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1037948541.HKD","LU2324357040.USD","IDNA","LU0861579265.USD","SG9999015945.SGD","LU0058720904.USD","GNOM","IE00BKVL7J92.USD","BIB","BK4583","BK4550","LU2357627491.SGD","BK4568","BK4139","LU0114720955.EUR","LU1934455277.USD","LU1934455194.USD","TBXU","MEDI","LU2468319806.SGD","GILD","LU0109394709.USD","LU1674673691.USD","IE00B7SZLL34.SGD","LU1674673428.USD","LU0889565916.HKD","SG9999015952.SGD","BK4534","BK4588","LU0320765992.SGD","LU0965508806.USD","IBBQ","BK4551","LU1061106388.HKD","LU1066053197.SGD","MRNY","BBH","LU0965509010.AUD","MRNA","IE00B19Z3581.USD","BK4533","MRNX","BMED","SG9999015986.USD","LU0965509283.SGD","WDNA","LGHT","LU1571399168.USD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662403857","title":"Twist Bioscience CEO Emily Leproust Sells USD 6.28 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662403857","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662403857?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:06","pubTimestamp":1787861174,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily Leproust sells USD 6.28 million in common sharesTwist Bioscience CEO Emily M. Leproust sold 41,570 shares on Aug. 25, 2026 at $150.56 to $154.45.Direct holdings fell to 770,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL4CsHyC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience CEO Emily Leproust Sells USD 6.28 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST","BK4139","BK4585","IDNA","WDNA","ARKG","GNOM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080060","title":"Moderna Wins FDA Approval for Updated 2026-2027 COVID-19 Vaccines Targeting JN.1-Lineage XFG Subvariant","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080060","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080060?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860727,"startTime":"0","endTime":"0","summary":"Moderna wins FDA approval for updated 2026-2027 COVID-19 vaccines targeting JN.1-lineage XFG subvariantFDA cleared Moderna’s updated 2026-2027 COVID-19 vaccine formulas targeting the JN.1-lineage XFG ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL395HN3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4551","MRNX","MRNY","BK4533","BK4585","BK4588","IDNA","GNOM","BK4534","BK4501","LGHT","BK4532","WDNA","MRNA","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662800610","title":"Moderna - FDA Approved Sbla for 2026-2027 Formulas for Spikevax and Mnexspike","url":"https://stock-news.laohu8.com/highlight/detail?id=2662800610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662800610?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860725,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNA","BK4534","BK4532","BK4501","BK4568","MRNY","MRNX","BK4551","GNOM","WDNA","BK4548","BK4585","LGHT","BK4139","BK4533","IDNA","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080096","title":"Moderna - Updated Formula for Spikevax is NOW Approved for Individuals 6 Months Through 64 Years of Age with at Least One Underlying Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080096?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860725,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O15C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4568","LGHT","BK4501","BK4588","MRNX","IDNA","BK4585","WDNA","BK4533","BK4534","BK4548","MRNA","GNOM","MRNY","BK4551","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080095","title":"Moderna: Updated Covid-19 Vaccines Expected Available in Coming Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080095?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860725,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O15C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","MRNY","BK4532","LGHT","BK4501","WDNA","BK4548","BK4568","MRNX","MRNA","IDNA","BK4139","BK4551","GNOM","BK4534","BK4588","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808054","title":"Moderna Inc Stock (MRNA) Moved Down by 5.69% on Aug 27: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808054","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662808054?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:15","pubTimestamp":1787858128,"startTime":"0","endTime":"0","summary":"• Moderna announced a proposed two billion dollar convertible senior notes private placement.\n• The pullback followed profit-taking after positive Phase 3 clinical trial developments.\n• Annual revenue stands at $1.94 billion alongside a net profit of $-2.82 billion.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262136721-market-movers-mrna-20260827","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4551","BK4501","MRNY","BK4532","GNOM","BK4585","BK4588","LGHT","MRNX","BK4139","MRNA","IDNA","BK4548","WDNA","BK4568","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662017084","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662017084","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662017084?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:03","pubTimestamp":1787850204,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF  shedding 0.7%.The iShares Biotechnology ETF  was fractionally lower.In corporate news, Moderna  shares fell 5.6% after it said Thursday it plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","IBB","LABU","BK4581","FDN","MRNX","BK4568","BK4534","LU0029874061.USD","LGHT","BK4137","STT","WDNA","XBI","BK4532","GNOM","HCSG","BK4501","MRNY","BK4139","LU0128526141.USD","BK4585","BK4533","BK4548","IDNA","MRNA","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662008458","title":"Revolution Medicines' Rasonque Label Expands Commercial Opportunity, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662008458","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662008458?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:21","pubTimestamp":1787847665,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) receiving a broader-than-expected Food and Drug Administration label for Rasonque strengthens its commercial outlook, Oppenheimer said.Management emphasized that the label ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJJMRZ35.SGD","BBH","IE00B4R5TH58.HKD","RVMD","CANC","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4139","IDNA","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD","IE0009354923.USD","PTH","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662112081","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2662112081","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662112081?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:00","pubTimestamp":1787846415,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeSalesforce, Inc.CRM.N+19.0%CrowdStrike Holdings, Inc.CRWD.OQ+17.6%Veeva Systems Inc.VEEV.N+16.6%Palo Alto Networks, Inc.PANW.OQ+11.7%Synopsys, Inc.SNPS.OQ+11.4%Bottom PerformersPercent ChangeHormel Foods CorpHRL.N-8.6%Moderna IncMRNA.OQ-7.1%HP IncHPQ.N-5.9%Best Buy Co., Inc.BBY.N-4.4%Tapestry, Inc.TPR.N-4.0%As of 12:00 p.m., the S&P 500.SPXgained 48.19 points, or 0.63%, to 7,724.03 and had posted 10 new 52-week highs and 6 new lows.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL8N44O1NY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ81514606.USD","SNPX","BK4579","LU0289739343.SGD","LU2095319765.USD","LU1316542783.SGD","IE00BZ9MQY76.HKD","SPYV","TSPY","LU2413666426.HKD","LU0820561909.HKD","HIBS","LU2063271972.USD","IE00BQXX3F31.USD","LU0057025933.USD","LU0130517989.USD","SG9999001424.SGD","LU1721428933.USD","LGHT","LU1201861249.SGD","LU1989764664.SGD","SPUU","LU0310799852.SGD","LU1989764748.USD","LU0477156953.USD","LU0289739699.SGD","SPHQ","IE0034235188.USD","IJH","SFY","AIPI","LU1064131342.USD","LU1303367103.USD","LU0006061336.USD","BK4550","LU0942090050.USD","HPQ","LU0130102774.USD","LU2087625088.SGD","LU1235294995.USD","LU1992135472.HKD","LU2264538146.SGD","LU0234570918.USD","LU1861215975.USD","LU2433249047.HKD","BK4527","BK4532","LU1992135399.USD","LU0238689110.USD","LU0124676726.USD","LU0170899867.USD","LU0251131958.USD","LU0266013472.USD","IE00B19Z8X17.USD","BK4076","MRNX","XDTE","IE00BJTD4V19.USD","LU0127658192.USD","ALLW","BK4607","IJR","LU0321505868.SGD","LU0347712357.USD","LU0130103400.USD","LU1803068979.SGD","SPXU","LU1815333072.USD","LU0234572021.USD","IE00BKVL7J92.USD","IE00BMPRXR70.SGD","GPIX","SPLV","CRMG","LU0058720904.USD","LU1861214812.USD","BK4023","LU0306807586.USD","LU0820562030.AUD","LU0211328371.USD","BK4560","LU2023250843.SGD","LU2272731600.USD","IDNA","STYL","LU0314104364.USD","LU1551013342.USD","CRM","BK4516","IE00BKPKM429.USD","LU1814569148.SGD","SPYQ","LU1951200564.SGD","LU0823434583.USD","WCBR","IE00B19Z9Z06.USD","IE00BMPRXN33.USD","MRNY","LU0963586101.USD","SGXZ51526630.SGD","BK4561","GNOM","RSPU","SPYM","SPYU","IVW","VEEV","LU2361044865.SGD","LU0980610538.SGD","SSO","VEU","BK4538","LU0072461881.USD","BK4533","LU1267930227.SGD","LU2361044949.HKD","LU0823421416.USD","PRNT","LU0354030511.USD","LU0689626769.HKD","LU0889566641.SGD","LU0130518102.USD","LU0943347566.SGD","LU0353189680.USD","SMAX","CIBR","LU1917777945.USD","LU0957791311.USD","LU2125909916.SGD","LU0868494617.USD","LU2357305700.SGD","CRWL","LU0109392836.USD","LU2023250504.SGD","BK4613","LU0348723411.USD","JEPI","LU1169590202.USD","HAKY","LU2272731782.SGD","SPMO","BK4567","AIFD","LU1144417596.USD","LU2361045086.USD","HIBL","LU2244417387.USD","LU2098885051.SGD","LU2360107325.USD","LU1267930490.SGD","LU2355687059.USD","SH","BK4543","LU0187121727.USD","LU1791710582.SGD","LU0289961442.SGD","LU2236285917.USD","IE00BQXX3D17.EUR","ETFT","SPDN","LU0225284248.USD","LU1804176565.USD","LU1854104046.USD","LU0528227936.USD","LU0390134368.USD","BK4501","LU1712237335.SGD","IVE","LU2247934214.USD","LU1923623000.USD","LU0511384066.AUD","LU0070302665.USD","TPR","IE00BQXX3C00.GBP","WLDR","LU2210149790.SGD","BK4170","LU1951198990.SGD","LU2756315318.SGD","LU2211814178.USD","BK4139","MMAX","LU1267930813.SGD","RSPA","LU2265009873.SGD","LU0052756011.USD","LU0061474960.USD","IE00B894F039.SGD","LU1974910355.USD","BK4551","LU1169589451.USD","LU1815336760.USD","GSLC","LU2461242641.AUD","XYLD","VV","LU0106261372.USD","SPYG","LU1046421795.USD","SCHB","SNPS","BK4505","CRWC","LU2413666699.HKD","SPY","LU1861219969.SGD","LU2125909593.SGD","BK4588","LU2286300806.USD","SG9999004303.SGD","LU2458330169.SGD","LU0320765489.SGD","SGXZ99366536.SGD",".SPX","LU0081259029.USD","SPYD","LU1201861165.SGD","LU0006306889.USD","LU0211327993.USD","IVV","LU0472753341.HKD","LU0742534661.SGD","VOOG","LU1551013425.SGD","LU1642822529.SGD","CRWD","LU2125909247.SGD","LU1623119135.USD","DMAX","BK4202","LU0823421333.USD","IHAK","LU0096362180.USD","IE00B19Z9505.USD","LU0225771236.USD","IE00BZ199S13.USD","LU0321505439.SGD","HRL","MRNA","LU0157215616.USD","LU0354030438.USD","YSPY","VTI","LU1988902786.USD","MOAT","LU0128525689.USD","BK4528","LU0557290698.USD","BK4504","LU1923622291.USD","LU2211815571.USD","LU0198837287.USD","LU0642271901.SGD","LU0889565833.HKD","BK4608","SPGP","BMAY","BK4535","VOO","LU0225283273.USD","RSP","UPRO","SPXL","LU1821325948.USD","EKG","WCLD","XLG","LU1861220033.SGD","LU2458330243.SGD","SPXS","SGXZ23171101.USD","LU0310800965.SGD","LU0082616367.USD","LU1366333091.USD","LU0823434740.USD","LU0306806265.USD","LU0689472784.USD","SPHD","NOBL","LU2360107168.USD","LU1923622614.USD","VTV","PALD","LU0820561818.USD","LU1854103824.USD","LU0048573561.USD","LU0648000940.SGD","LU0985481810.HKD","BUG","BK4581","LU0719512351.SGD","LU0792757196.USD","LU1496350502.SGD","LU1720051017.SGD","LU0353189763.USD","LU0868494708.USD","BK4548","BK4212","LU1548497426.USD","BBY","IE00B19Z9P08.USD","LU2210150020.SGD","LU0069063385.USD","WDNA","DBSC","ACWI","SPYH","LU0251142724.SGD","SCHX","PANG","LU0957808578.USD","RSPN","BK4097","VBK","LU1823568750.SGD","PALU","LU0444971666.USD","LU0477156797.USD","ITOT","LU2756315664.SGD","BK4568","IE00BJTD4N35.SGD","BK4598","LU2106854487.HKD","SDS","BK4534","IE00BZ1G4Q59.USD","CLOD","IGV","LU2125909759.SGD","LU0162691827.USD","LU0208291251.USD","LU1720051108.HKD","SPUS","LU2290526834.HKD","LU0267386448.USD","LU1633808545.USD","LU0648001328.SGD","LU1791710400.SGD","LU1496350171.SGD","IE00B19Z8W00.USD","PSWD","BK4167","SPAM","BK4585","PANW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662088011","title":"Moderna Shares Down 3.6% After Co Announces $2 Bln Convertible Debt Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2662088011","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662088011?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:32","pubTimestamp":1787837569,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O1CI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNY","WDNA","BK4532","LGHT","BK4534","BK4588","BK4501","MRNA","BK4533","GNOM","IDNA","MRNX","BK4139","BK4551","BK4585","BK4548","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662408355","title":"Moderna Stock (MRNA) Slides 3% on Plans for a $2B Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2662408355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662408355?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:22","pubTimestamp":1787836961,"startTime":"0","endTime":"0","summary":"Moderna stock was down on Thursday after the company revealed private placement plans that include an offer for $2 billion of convertible senior no...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-stock-mrna-slides-3-on-plans-for-a-2b-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-stock-mrna-slides-3-on-plans-for-a-2b-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4501","BK4532","MRNX","BK4551","BK4568","MRNA","BK4534","BK4548","IDNA","GNOM","MRNY","LGHT","WDNA","BK4533","BK4139","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662085942","title":"AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662085942","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662085942?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:01","pubTimestamp":1787835660,"startTime":"0","endTime":"0","summary":"Video webcast now availablehere OCALA, Fla., Aug.  27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM)(“AIM” or the “Company”) today announced that it participated in the Virtual Inv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352073/29489/en/aim-immunotech-participates-in-the-virtual-investor-why-now-on-demand-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","MEDX","HYLG","GDOC","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662704735","title":"Moderna Falls After Unveiling $2 Bln Convertible Debt Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2662704735","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662704735?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:56","pubTimestamp":1787831803,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna falls after unveiling $2 bln convertible debt plans** Vaccine maker Moderna'sMRNA.Oshares down 5.2% premarket to $141.94 as it looks to raise capital** Cambridge, Massachusetts-based MRNA announces private offering of $2 bln convertible bonds due 2032** Co intends to use net offering proceeds for general corp purposes, including to grow its oncology business and to repay debt** It also intends to use some proceeds to pay cost of capped calls, derivative transactions employed to help mitigate potential dilution** Through Weds, MRNA's shares surged 173% this month in wake ofnews its skin cancer vaccine, combined with Merck'sMRK.NKeytruda, reduced risk of recurrence and spread of melanoma in a late-stage trial** MRNA stock up about 400% YTD for nearly $60 bln market cap as of last close","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O0Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LGHT","MRNY","BK4551","MRNA","BK4534","IDNA","BK4533","BK4588","BK4548","BK4532","BK4139","WDNA","MRNX","GNOM","BK4501","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662670413","title":"Moderna to Sell $2 Billion Convertible Notes in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2662670413","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662670413?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:44","pubTimestamp":1787831040,"startTime":"0","endTime":"0","summary":"Moderna plans to sell $2 billion of convertible senior notes due 2032 in a private placement.Moderna on Thursday said it will use proceeds from the sale for general purposes, which the Cambridge, Mass., vaccine maker said could include investing in its oncology business and debt repayment.Moderna and partner Merck last week said an experimental mRNA-based vaccine succeeded in preventing cancer from coming back or spreading in a study of high-risk melanoma patients.Shares of Moderna nearly tripled last Wednesday on the news, closing at a new three-year high of $174.38, but the stock has pulled back since then and was recently down 5.3% to $141.71 in premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4585","BK4534","MRNY","WDNA","BK4501","BK4532","BK4548","GNOM","BK4551","BK4588","MRNX","BK4139","IDNA","BK4533","MRNA","LGHT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":4,"totalSize":320,"code":"91000000","status":"200"}]}}